Internal Medicine

Drug-resistant, true extramedullary myeloma (EMD) presents a major clinical challenge. This aggressive disease subtype is noncontiguous … Breakthrough: Dual-Targeting Myeloma Agents for EMDRead more

Mucopolysaccharidosis Type II (MPS II), also called Hunter syndrome, is a progressive, rare genetic lysosomal disorder. … Game Changer? New Enzyme Therapy Penetrates Brain in MPS IIRead more

Cardiogenic Shock is a critical syndrome. It occurs when heart function severely declines, leading to low … High Mortality Alert: New Strategies for Cardiogenic ShockRead more

An important new study on Statins in Diabetes provides clear evidence for primary cardiovascular disease (CVD) … New Study: Should All Patients with Diabetes Get Statins?Read more

An updated systematic review provides clarity on the efficacy and safety of cannabinoids for chronic pain … THC vs. CBD for Chronic Pain: What Clinicians Need to KnowRead more

The development of a new once-weekly HIV treatment regimen offers a significant step forward in managing … Once-Weekly HIV Pill: Efficacy Matches Daily Standard in Phase 2Read more

Once-weekly HIV treatment with the islatravir (ISL) and lenacapavir (LEN) combination shows strong potential to simplify … Once-Weekly Pill: A Breakthrough for HIV Treatment AdherenceRead more

The SURPASS-CVOT trial offers critical data comparing the cardiovascular safety of tirzepatide against dulaglutide in patients … Critical Trial Update: Tirzepatide vs. Dulaglutide for CV RiskRead more

Clinical guidelines recommend using Bisphosphonates for CRPS, but evidence supporting this treatment has been limited. A … Bisphosphonates for CRPS: Are They Safe and Effective?Read more

The landmark Women Informed to Screen Depending on Measures of Risk (WISDOM) randomised clinical trial provides … Is Risk-Based Screening the Future for Breast Cancer?Read more